Aslamuzzaman Kazi

Also affiliated with Virginia Cancer Institute, VCU Massey Comprehensive Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Global Phosphoproteomics Reveal CDK Suppression as a Vulnerability to KRas Addiction in Pancreatic Cancer”.

Global Phosphoproteomics Reveal CDK Suppression as a Vulnerability to KRas Addiction in Pancreatic Cancer

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4781

N/A

0DataRank · unranked

36 citations

Liwei Chen, Shengyan Xiang, Rajanikanth Vangipurapu, Hua Yang, Francisca Beato +11 more

Discovery of KRB-456, a KRAS G12D Switch-I/II Allosteric Pocket Binder That Inhibits the Growth of Pancreatic Cancer Patient-derived Tumors

Cancer Research Communications(2023)10.1158/2767-9764.crc-23-0222

N/A

0DataRank · unranked

18 citations

Alok Ranjan, Vasantha Kumar M.V., Bogos Agianian, Martin Garcia Chavez, Vignesh Vudatha +14 more

Novel mutant KRAS addiction signature predicts response to the combination of ERBB and MEK inhibitors in lung and pancreatic cancers

iScience(2023)10.1016/j.isci.2023.106082

N/A

0DataRank · unranked

10 citations

Aslamuzzaman Kazi, Alok Ranjan, Rui Wang, Saı̈d M. Sebti, Katarzyna M. Tyc

Inhibiting Isoprenylation Suppresses FcεRI-Mediated Mast Cell Function and Allergic Inflammation

The Journal of Immunology(2023)10.4049/jimmunol.2200862

N/A

0DataRank · unranked

4 citations

Sydney Ann Kee, Anuj Tharakan, Aslamuzzaman Kazi, Jason R. Burchett, Elizabeth Motunrayo Kolawole +9 more

Data from Global Phosphoproteomics Reveal CDK Suppression as a Vulnerability to KRas Addiction in Pancreatic Cancer

(2023)10.1158/1078-0432.c.6530501

N/A

0DataRank · unranked

0 citations

Liwei Chen, Shengyan Xiang, Rajanikanth Vangipurapu, Hua Yang, Francisca Beato +11 more

FGTI-2734 Inhibits ERK Reactivation to Overcome Sotorasib Resistance in KRAS G12C Lung Cancer

Journal of Thoracic Oncology(2024)10.1016/j.jtho.2024.11.022

N/A

0DataRank · unranked

6 citations

Hitesh Vasiyani, Deblina Ghosh, Dipankar Bandyopadhyay, Rachit D. Shah, Vignesh Vudatha +3 more

Design and Evaluation of Bivalent K‐Ras Inhibitors That Target the CAAX Binding Site and the Acidic Surface of Farnesyltransferase and Geranylgeranyltransferase I

Chemistry - A European Journal(2025)10.1002/chem.202500306

N/A

0DataRank · unranked

2 citations

Rania Omer, Fumitoshi Sugino, Nanami Ogino, Yoshihisa Inoue, Aslamuzzaman Kazi +4 more

Geranylgeranyl transferase‐1 inhibitor GGTI ‐2417 enhances the anti‐tumour efficacy of histone deacetylase inhibitors in different T‐cell lymphoma lines

British Journal of Haematology(2025)10.1111/bjh.70188

N/A

0DataRank · unranked

1 citations

Lin Li, Jewel Nkwocha, Hitesh Vasiyani, Aslamuzzaman Kazi, Saı̈d M. Sebti +2 more